SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is experiencing significant volatility driven by a spillover of panic selling from the South Korean market, where semiconductor heavyweights like Samsung and SK Hynix faced downward pressure following profit-taking and earnings reactions. While the community remains deeply divided, many retail investors are actively discussing whether this pullback is a temporary manufactured dip designed to flush out weak hands or a signal to scale into positions for the long-term AI-driven memory cycle.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is experiencing significant volatility as market participants debate whether recent price action represents a sustainable rebound or a manipulative bull trap driven by AI-sector hype. Community discussions are heavily focused on the index's reaction to international market instability, semiconductor performance, and the influence of institutional algorithmic trading on intraday movements.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares (SOXL) is trending due to heightened volatility as traders react to a sharp pullback in the semiconductor sector driven by negative sentiment in memory chip stocks like Micron. While some community members view the sell-off as a temporary wash-out and a prime buying opportunity, others are warning of a larger trend reversal and a potential bubble pop, leading to intense debate between bullish 'dip buyers' and bearish traders utilizing inverse instruments.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk Corp is seeing significant volatility as market participants weigh strong memory demand and upcoming major earnings catalysts against the sector's recent technical pullback. Community sentiment is deeply divided, with bulls pointing to the expanding AI infrastructure cycle and high-bandwidth memory needs, while bears focus on potential overvaluation and institutional rebalancing after a rapid year-to-date rally.

Roundhill ETF Trust - Roundhill Memory ETF

Roundhill Memory ETF (DRAM) is facing intense volatility as community members react to a broader semiconductor sell-off, exacerbated by concerns over excess supply and aggressive price movements in South Korean memory stocks. Investors are actively debating whether this drawdown is a temporary shakeout before a rebound catalyzed by upcoming industry events or a structural shift marking the end of the current memory cycle.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is trending following a major 20-year lease agreement with AI startup Anthropic, which investors view as a pivotal validation of the company's transition into a tier-one AI infrastructure provider. While the community is actively debating the stock's recent volatility and potential for a short squeeze, many are focused on the long-term bullish implications of securing high-quality, contracted revenue that differentiates the company from pure-play crypto miners.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending after reporting a quarterly delivery beat and raising its full-year outlook, fueling community debates about the company's long-term production scale versus ongoing concerns regarding capital raises and dilution. While some investors are cheering the positive momentum and institutional interest, others remain skeptical, citing continued cash burn and the stock's tendency to face selling pressure following recent rallies.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius is facing intense bearish pressure as community members debate whether the stock is an oversold growth opportunity or caught in a negative sentiment cycle. Investors are currently hyper-focused on the company's Alani Nu integration and international expansion, while short sellers are aggressively targeting the name, leading to volatile price action and ongoing discussions about potential buyout rumors.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is facing intense volatility as the community debates whether Meta's reported plans to commercialize excess compute capacity signal a competitive threat to specialized AI cloud providers. While bearish voices highlight the potential for margin compression and overvaluation, bulls argue that demand remains structurally constrained and point to the company's multi-billion dollar contracted backlog and rapid infrastructure expansion as evidence that the long-term growth thesis remains intact.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is facing significant selling pressure and community frustration as investors grapple with conflicting signals regarding next-generation AI architecture delays, which the company has officially denied. Despite robust underlying fundamentals and massive AI infrastructure demand, the stock continues to struggle with momentum, leaving the community divided between those holding long-term for institutional accumulation and those frustrated by persistent price stagnation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Biohaven Completes Enrollment in RISE 3 Pivotal Focal Epilepsy Study with Opakalim, a Selective Kv7.2/7.3 Activator

Biohaven Completes Enrollment in RISE 3 Pivotal Focal Epilepsy Study with Opakalim, a Selective Kv7.2/7.3 Activator Biohaven Completes Enrollment in RISE 3 Pivotal Focal Epilepsy Study with Opakalim, a Selective Kv7.2/7.3 Activator PR Newswire NEW HAVEN, Conn., June 30, 2026 Enrollment complete in...

Why Is BHVN Stock Falling Premarket?

Equity

BofA downgraded Biohaven Pharmaceutical to ‘Underperform’ from ‘Neutral’ and cut the price target to $11, indicating a downside potential of about 26% from the stock’s previous close. 

Biohaven Advances a New Class of Precision Immunology Therapies: First MoDE Extracellular Protein Degrader, BHV-1300, Begins Phase 3 Pivotal Trial in Graves' Disease

Biohaven Advances a New Class of Precision Immunology Therapies: First MoDE Extracellular Protein Degrader, BHV-1300, Begins Phase 3 Pivotal Trial in Graves' Disease Biohaven Advances a New Class of Precision Immunology Therapies: First MoDE Extracellular Protein Degrader, BHV-1300, Begins Phase 3...

Why Is TG Therapeutics (TGTX) Down 5.7% Since Last Earnings Report?

TG Therapeutics (TGTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Myriad (MYGN) Up 7.1% Since Last Earnings Report: Can It Continue?

Myriad (MYGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Biohaven Reports First-in-Human Dosing of Oral PKM2 Modulator, BHV-8100, Targeting Metabolic Restoration and Immunomodulation

Biohaven Reports First-in-Human Dosing of Oral PKM2 Modulator, BHV-8100, Targeting Metabolic Restoration and Immunomodulation Biohaven Reports First-in-Human Dosing of Oral PKM2 Modulator, BHV-8100, Targeting Metabolic Restoration and Immunomodulation PR Newswire NEW HAVEN, Conn., June 1, 2026...

Biohaven Reports Positive Clinical Biomarker and Patient Data: First MoDE and TRAP Extracellular Protein Degraders Achieve Deep, Rapid, Selective Lowering of Disease-Driving Antibodies in Graves' Disease and IgA Nephropathy

Biohaven Reports Positive Clinical Biomarker and Patient Data: First MoDE and TRAP Extracellular Protein Degraders Achieve Deep, Rapid, Selective Lowering of Disease-Driving Antibodies in Graves' Disease and IgA Nephropathy Biohaven Reports Positive Clinical Biomarker and Patient Data: First MoDE...

Biohaven Reports New Clinical Data in Epilepsy with Opakalim, a Selective Kv7.2/7.3 Activator, Highlighting Seizure Control and Markedly Differentiated Tolerability Profile

Biohaven Reports New Clinical Data in Epilepsy with Opakalim, a Selective Kv7.2/7.3 Activator, Highlighting Seizure Control and Markedly Differentiated Tolerability Profile Biohaven Reports New Clinical Data in Epilepsy with Opakalim, a Selective Kv7.2/7.3 Activator, Highlighting Seizure Control...

Biohaven (NYSE:BHVN) Trading Down 7.7% After Analyst Downgrade

Biohaven (NYSE:BHVN) Stock Price Down 7.7% on Analyst Downgrade...

Biohaven Ltd. (BHVN) Upgraded to Buy: Here's Why

Biohaven Ltd. (BHVN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

Biohaven Ltd

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$16.05
Prev Close	$15.96
Open	$16.10
Dividend Yield	0.00%
50-Day Moving Average	$11.32
Beta	1.58
Avg. Volume	3.97M
PE Ratio	-2.83

52-Week High	$18.57
52-Week Low	$7.48
Market Capitalization	$2.4B
EPS (Annual)	-$6.86
Price to Book	18.65
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

BHVNBiohaven Pharmaceutical Holding Company Ltd

Latest BHVN News